PTC Therapeutics Inc (PTCT)
35.71
-1.18
(-3.20%)
USD |
NASDAQ |
Jun 14, 10:48
PTC Therapeutics Cash and Short Term Investments (Quarterly): 884.81M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 884.81M |
December 31, 2023 | 876.74M |
September 30, 2023 | 294.81M |
June 30, 2023 | 337.94M |
March 31, 2023 | 286.30M |
December 31, 2022 | 410.70M |
September 30, 2022 | 288.43M |
June 30, 2022 | 505.54M |
March 31, 2022 | 587.79M |
December 31, 2021 | 773.38M |
September 30, 2021 | 867.94M |
June 30, 2021 | 947.08M |
March 31, 2021 | 988.41M |
December 31, 2020 | 1.104B |
September 30, 2020 | 1.141B |
June 30, 2020 | 498.89M |
March 31, 2020 | 595.86M |
December 31, 2019 | 686.56M |
September 30, 2019 | 708.65M |
June 30, 2019 | 363.54M |
March 31, 2019 | 407.16M |
December 31, 2018 | 227.59M |
September 30, 2018 | 249.40M |
Date | Value |
---|---|
June 30, 2018 | 296.11M |
March 31, 2018 | 178.27M |
December 31, 2017 | 191.25M |
September 30, 2017 | 169.31M |
June 30, 2017 | 181.07M |
March 31, 2017 | 202.58M |
December 31, 2016 | 231.67M |
September 30, 2016 | 248.34M |
June 30, 2016 | 272.89M |
March 31, 2016 | 298.71M |
December 31, 2015 | 338.92M |
September 30, 2015 | 371.52M |
June 30, 2015 | 255.22M |
March 31, 2015 | 280.47M |
December 31, 2014 | 315.24M |
September 30, 2014 | 209.39M |
June 30, 2014 | 226.86M |
March 31, 2014 | 246.58M |
December 31, 2013 | 142.47M |
September 30, 2013 | 157.23M |
June 30, 2013 | 165.68M |
March 31, 2013 | 54.75M |
December 31, 2012 | 2.726M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
286.30M
Minimum
Mar 2023
1.141B
Maximum
Sep 2020
657.40M
Average
641.21M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Pfizer Inc | 11.93B |
Sarepta Therapeutics Inc | 1.391B |
Biogen Inc | 1.074B |
Catalyst Pharmaceuticals Inc | 310.41M |
Oragenics Inc | 2.072M |